Song et al. established a Cox regression model with a least absolute shrinkage and selection operator for CT images to predict the progression-free survival of stage-IV epidermal growth factor receptor (EGFR)-mutated NSCLC patients being treated with EGFR tyrosine kinase inhibitors (19). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.